BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4282585)

  • 21. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the immune response to canine morbillivirus in multiple sclerosis a reflex of the measles pre-existing immunity?
    Mititelu G; Stirbu C; Bourceanu I; Mititelu T
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(4):741-2. PubMed ID: 3452869
    [No Abstract]   [Full Text] [Related]  

  • 23. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.
    Visscher BR; Sullivan CB; Detels R; Madden DL; Sever JL; Terasaki PI; Park MS; Dudley JP
    Neurology; 1981 Sep; 31(9):1142-5. PubMed ID: 6267516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA types and immunity in multiple sclerosis.
    Visscher BR; Myers LW; Ellison GW; Malmgren RM; Detels R; Lucia MV; Madden DL; Sever JL; Park MS; Coulson AH
    Neurology; 1979 Dec; 29(12):1561-5. PubMed ID: 574218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis immunogenetics. A possible correlation with human leukocyte HL-A antigens.
    Cazzullo CL; Smeraldi E
    Arzneimittelforschung; 1975 Nov; 25(11):1826-8. PubMed ID: 1106444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
    St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients.
    Robinson-Agramonte M; Reiber H; Cabrera-Gomez JA; Galvizu R
    Acta Neurol Scand; 2007 May; 115(5):312-8. PubMed ID: 17489941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the immune response in multiple sclerosis and other inflammatory diseases of the central nervous system.
    Kinnman J
    Acta Neurol Scand Suppl; 1981; 81():1-96. PubMed ID: 6939210
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural killer cell activity in multiple sclerosis.
    Hauser SL; Ault KA; Levin MJ; Garovoy MR; Weiner HL
    J Immunol; 1981 Sep; 127(3):1114-7. PubMed ID: 6167616
    [No Abstract]   [Full Text] [Related]  

  • 30. Measles virus antibodies in multiple sclerosis.
    Cendrowski W; Niedzielska K
    Acta Med Pol; 1974; 15(4):189-202. PubMed ID: 4140677
    [No Abstract]   [Full Text] [Related]  

  • 31. Histocompatibility-linked immune-response determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Hansen GS; Nielsen LS; Thomsen M; Svejgaard A
    Transplant Proc; 1973 Dec; 5(4):1791-6. PubMed ID: 4130083
    [No Abstract]   [Full Text] [Related]  

  • 32. Histocompatibility determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Platz PJ; Svejgaard A
    Transplant Rev; 1975; 22():148-63. PubMed ID: 46643
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
    Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenetical aspects of multiple sclerosis with special regard to the HLA-histocompatibility system.
    Bertrams J
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):506-15. PubMed ID: 147092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis: etiology and epidemiology.
    Inverso MJ; Dolezal JL; Rath GA; Jung BA
    J Am Optom Assoc; 1979 Feb; 50(2):185-7. PubMed ID: 458098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Major histocompatibility system in multiple sclerosis].
    Oger J; Sabouraud O; Fauchet R; Genetet N; Menault F; Genetet B
    Rev Neurol (Paris); 1976 Feb; 132(2):89-97. PubMed ID: 973072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confounding factors in HLA-DW 2 typing of human leucocytes.
    Källén B; Löw B; Nilsson O
    Clin Exp Immunol; 1977 Jan; 27(1):55-62. PubMed ID: 139221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral and bacterial antibody responses in multiple sclerosis.
    Vartdal F; Vandvik B; Norrby E
    Ann Neurol; 1980 Sep; 8(3):248-55. PubMed ID: 6254433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response.
    Jacobi C; Lange P; Reiber H
    J Neuroimmunol; 2007 Jul; 187(1-2):139-46. PubMed ID: 17512988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.